P38852
Gene name |
LIN1 (YHR156C) |
Protein name |
Protein LIN1 |
Names |
|
Species |
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) |
KEGG Pathway |
sce:YHR156C |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P38852
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P38852-F1 | Predicted | AlphaFoldDB |
11 variants for P38852
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| s08-412284 | 42 | S>R | No | SGRP | |
| s08-412130 | 94 | D>N | No | SGRP | |
| s08-412079 | 111 | G>S | No | SGRP | |
| s08-412051 | 120 | G>D | No | SGRP | |
| s08-411964 | 149 | A>V | No | SGRP | |
| s08-411951 | 153 | D>E | No | SGRP | |
| s08-411812 | 200 | L>F | No | SGRP | |
| s08-411754 | 219 | K>R | No | SGRP | |
| s08-411650 | 254 | V>I | No | SGRP | |
| s08-411602 | 270 | I>F | No | SGRP | |
| s08-411430 | 327 | R>Q | No | SGRP |
No associated diseases with P38852
1 regional properties for P38852
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | GYF domain | 282 - 340 | IPR003169 |
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| chromatin | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| spliceosomal complex | Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA. |
| U5 snRNP | A ribonucleoprotein complex that contains small nuclear RNA U5, a heptameric ring of Sm proteins, as well as several proteins that are unique to the U5 snRNP, most of which remain associated with the U5 snRNA both while the U5 snRNP is free or assembled into a series of spliceosomal complexes. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
1 GO annotations of biological process
| Name | Definition |
|---|---|
| mRNA splicing, via spliceosome | The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MKYTQYPNSS | KLKRNSDRRE | HDEKLSDELH | NQSTIYEDEE | LSRAEYDSDS | DSSVEDSTDN |
| 70 | 80 | 90 | 100 | 110 | 120 |
| ENSGKEMDEK | SYEKNEDHVE | DHRKRKKSKI | QLLDIAEFKK | ENLADLDYQI | GNSESKVEKG |
| 130 | 140 | 150 | 160 | 170 | 180 |
| VNIEPFNIDD | EIKHGVFDKD | GNYIKTENAT | ENDQQDNEEW | MNDVINTEEV | NRLEKEQSVK |
| 190 | 200 | 210 | 220 | 230 | 240 |
| TQNSRHYMVH | EALNLLKFFL | VDENETVLES | LGRLNKLRKI | AISKKNKSLK | YVIHGIELLS |
| 250 | 260 | 270 | 280 | 290 | 300 |
| DLINILEKKG | FSEVYEYNRL | KVQDAIEEEI | FDDSSRIVNH | KTKLWGFKWL | NKLDEYHGLY |
| 310 | 320 | 330 | |||
| TNYEMSYWQK | SYFKNSVIVK | FHSEPDRDEN | WIHVSCLSFM |